We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
-11.29%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.38B
AUM Growth
-$799M
Cap. Flow
-$109M
Cap. Flow %
-2.49%
Top 10 Hldgs %
5.78%
Holding
1,425
New
121
Increased
257
Reduced
318
Closed
105

Top Buys

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$21M
2
NUE icon
Nucor
NUE
+$15.4M
3
GIS icon
General Mills
GIS
+$13M
4
DOW icon
Dow Inc
DOW
+$11.2M
5
OXY icon
Occidental Petroleum
OXY
+$10.3M

Top Sells

Rank Stock Value
1
AR icon
Antero Resources
AR
+$17.7M
2
CL icon
Colgate-Palmolive
CL
+$15.8M
3
NSC icon
Norfolk Southern
NSC
+$15.4M
4
WAT icon
Waters Corp
WAT
+$11M
5
NTAP icon
NetApp
NTAP
+$10.6M

Sector Composition

Rank Sector Weight
1 Financials 27.17%
2 Energy 10.91%
3 Industrials 10.83%
4 Consumer Discretionary 9.97%
5 Technology 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GRTS
1276
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$56K ﹤0.01%
23,100
– –
SIOX
1277
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$56K ﹤0.01%
155,400
-89,500
-37% -$37.1K
NERV icon
1278
Minerva Neurosciences
NERV
$202M
$53K ﹤0.01%
16,148
-2
-0% -$8
OMIC
1279
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$52K ﹤0.01%
+450
New +$52.8K
OTRK
1280
DELISTED
Ontrak
OTRK
$51K ﹤0.01%
531
-389
-42% -$54.5K
INKT icon
1281
MiNK Therapeutics
INKT
$57.2M
$50K ﹤0.01%
3,550
– –
OGEN icon
1282
Oragenics
OGEN
$2.45M
$49K ﹤0.01%
78
– –
TNXP icon
1283
Tonix Pharmaceuticals
TNXP
$184M
$48K ﹤0.01%
+2
New +$148K
IDW
1284
DELISTED
IDW Media Holdings
IDW
$48K ﹤0.01%
35,500
+15,000
+73% +$22.2K
VRCA icon
1285
Verrica Pharmaceuticals
VRCA
$100M
$47K ﹤0.01%
2,455
– –
AMZE
1286
Amaze Holdings
AMZE
$1.41M
$47K ﹤0.01%
136
– –
ACOR
1287
DELISTED
Acorda Therapeutics
ACOR
$47K ﹤0.01%
5,085
-7,120
-58% -$127K
BIMI
1288
DELISTED
BIMI International Medical Inc. Common Stock
BIMI
$46K ﹤0.01%
7,276
– –
TTOO
1289
DELISTED
T2 Biosystems, Inc
TTOO
$46K ﹤0.01%
57
– –
PHGE icon
1290
BiomX
PHGE
$1.7M
$43K ﹤0.01%
309
– –
CPHI icon
1291
China Pharma Holdings
CPHI
$47.8M
$42K ﹤0.01%
390
– –
JOB icon
1292
GEE Group
JOB
$22.6M
$41K ﹤0.01%
77,600
– –
KRON
1293
DELISTED
Kronos Bio
KRON
$41K ﹤0.01%
+11,400
New +$51.7K
ECOR icon
1294
electroCore
ECOR
$53.4M
$40K ﹤0.01%
5,239
-1,001
-16% -$7.24K
GLS
1295
DELISTED
Gelesis Holdings, Inc.
GLS
$40K ﹤0.01%
26,000
– –
CEI
1296
DELISTED
Camber Energy, Inc
CEI
$40K ﹤0.01%
2,000
– –
IMH
1297
DELISTED
Impac Mortgage Holdings Inc.
IMH
$40K ﹤0.01%
68,500
-100
-0.1% -$71
SDEV
1298
Stablecoin Development Corp
SDEV
$52.5M
$39K ﹤0.01%
25
– –
SUNE
1299
SUNation Energy
SUNE
$10.2M
– –
0
– –
LTRPA
1300
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$38K ﹤0.01%
50,000
– –
50 51
52
53 54

Similar funds

SNT
SIG North Trading Bala Cynwyd, Pennsylvania $4.98B AUM 36.24% 1-Year Est. Return
MA
Marshfield Associates Washington, District of Columbia $4.99B AUM 1.59% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5B AUM 11.9% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return
SIA
Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return

Bridgeway Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Bridgeway Capital Management held 1,425 positions worth $4.38B, down 15% from $5.17B the previous quarter. Its ten largest holdings account for 5.8% of the portfolio.

Bridgeway Capital Management's Q2 2022 filing shows 121 new, 257 increased, 318 reduced and 105 closed positions. Its largest new stake was Charles River Laboratories: 86,100 shares worth $18.4M. The largest sale was Antero Resources, an estimated $17.7M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 25% a quarter earlier, followed by Energy and Industrials.

  • Bridgeway Capital Management's largest Q2 2022 buy was Charles River Laboratories: 86,100 shares worth $18.4M.
  • Bridgeway Capital Management added most to Nucor in Q2 2022, an estimated $15.4M increase.
  • Bridgeway Capital Management's biggest Q2 2022 reduction was Antero Resources, cutting an estimated $17.7M.
  • Bridgeway Capital Management fully exited Colgate-Palmolive in Q2 2022, selling an estimated $15.8M.
  • Bridgeway Capital Management's ten largest holdings make up 5.8% of its $4.38B portfolio in Q2 2022.
  • Bridgeway Capital Management opened 121 new positions and closed 105 in Q2 2022.
  • Bridgeway Capital Management's portfolio value fell 15% quarter-over-quarter to $4.38B.

Based on Bridgeway Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.